Global Patient Recruitment for Clinical Trials Supply, Demand and Key Producers, 2026-2032

January 2026 | 163 pages | ID: G55F862D4D6BEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Patient Recruitment for Clinical Trials market size is expected to reach $ 6959 million by 2032, rising at a market growth of 9.8% CAGR during the forecast period (2026-2032).
Patient recruitment for clinical trials refers to specialized services that support the identification, screening, enrollment, and management of study participants for clinical research projects. These services typically involve multi-channel patient outreach, eligibility pre-screening, informed consent support, and enrollment tracking, enabling sponsors, CROs, and research sites to meet recruitment targets within required timelines while ensuring protocol compliance and data quality.
The market is primarily driven by the increasing number and complexity of clinical trials. Rising investment in drug development and the rapid growth of innovative therapies?such as oncology, rare diseases, biologics, and cell and gene therapies?have led to stricter inclusion/exclusion criteria and more fragmented patient populations, increasing reliance on professional recruitment services. In parallel, pressure to reduce trial timelines and costs encourages sponsors to outsource recruitment to specialized providers with data-driven and operational expertise. The adoption of digital recruitment tools, real-world data, and patient-centric engagement strategies further improves recruitment efficiency and reach, supporting continued market growth.
In global market, the largest three players are IQVIA, Thermo Fisher Scientific (PPD), and ICON plc, hold 28 percent of global market in 2024; while in China market, the largest three players are Baidu Health, Hangzhou Tigermed, occupied for more than 14% of China market in 2024.
This report studies the global Patient Recruitment for Clinical Trials demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Patient Recruitment for Clinical Trials, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Patient Recruitment for Clinical Trials that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Patient Recruitment for Clinical Trials total market, 2021-2032, (USD Million)
Global Patient Recruitment for Clinical Trials total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Patient Recruitment for Clinical Trials total market, key domestic companies, and share, (USD Million)
Global Patient Recruitment for Clinical Trials revenue by player, revenue and market share 2021-2026, (USD Million)
Global Patient Recruitment for Clinical Trials total market by Clinical Trial Phase, CAGR, 2021-2032, (USD Million)
Global Patient Recruitment for Clinical Trials total market by Therapeutic Area, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Patient Recruitment for Clinical Trials market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IQVIA, Thermo Fisher Scientific (PPD), ICON plc, Syneos Health, Parexel, Labcorp, Medpace, Inc., WCG Clinical, Science37, Baidu Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Patient Recruitment for Clinical Trials market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Clinical Trial Phase, and by Therapeutic Area. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Patient Recruitment for Clinical Trials Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Patient Recruitment for Clinical Trials Market, Segmentation by Clinical Trial Phase:
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Global Patient Recruitment for Clinical Trials Market, Segmentation by Client Type:
  • Pharmaceutical and Biotechnology Companies
  • CROs and Research Organizations
  • Others
Global Patient Recruitment for Clinical Trials Market, Segmentation by Recruitment Channel:
  • Online
  • Offline
Global Patient Recruitment for Clinical Trials Market, Segmentation by Therapeutic Area:
  • Oncology
  • Rare Disease
  • CNS and Psychiatric
  • Inflammatory Disorder
  • Infectious Disease
  • Others
Companies Profiled:
  • IQVIA
  • Thermo Fisher Scientific (PPD)
  • ICON plc
  • Syneos Health
  • Parexel
  • Labcorp
  • Medpace, Inc.
  • WCG Clinical
  • Science37
  • Baidu Health
  • Hangzhou Tigermed
  • AutoCruitment
  • Beijing Houpu Pharmaceutical
  • Clariness
  • Matthews Media Group (MMG)
  • Trialbee
  • Publicis
  • Worldwide Clinical Trials
  • Elixia
  • Shanghai Jsure
  • JD Health
  • Waterdrop Inc.
  • Antidote
Key Questions Answered
1. How big is the global Patient Recruitment for Clinical Trials market?
2. What is the demand of the global Patient Recruitment for Clinical Trials market?
3. What is the year over year growth of the global Patient Recruitment for Clinical Trials market?
4. What is the total value of the global Patient Recruitment for Clinical Trials market?
5. Who are the Major Players in the global Patient Recruitment for Clinical Trials market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Patient Recruitment for Clinical Trials Introduction
1.2 World Patient Recruitment for Clinical Trials Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Patient Recruitment for Clinical Trials Total Market by Region (by Headquarter Location)
  1.3.1 World Patient Recruitment for Clinical Trials Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032)
  1.3.3 China Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032)
  1.3.4 Europe Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032)
  1.3.5 Japan Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032)
  1.3.6 South Korea Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032)
  1.3.7 ASEAN Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032)
  1.3.8 India Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Patient Recruitment for Clinical Trials Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Patient Recruitment for Clinical Trials Consumption Value (2021-2032)
2.2 World Patient Recruitment for Clinical Trials Consumption Value by Region
  2.2.1 World Patient Recruitment for Clinical Trials Consumption Value by Region (2021-2026)
  2.2.2 World Patient Recruitment for Clinical Trials Consumption Value Forecast by Region (2027-2032)
2.3 United States Patient Recruitment for Clinical Trials Consumption Value (2021-2032)
2.4 China Patient Recruitment for Clinical Trials Consumption Value (2021-2032)
2.5 Europe Patient Recruitment for Clinical Trials Consumption Value (2021-2032)
2.6 Japan Patient Recruitment for Clinical Trials Consumption Value (2021-2032)
2.7 South Korea Patient Recruitment for Clinical Trials Consumption Value (2021-2032)
2.8 ASEAN Patient Recruitment for Clinical Trials Consumption Value (2021-2032)
2.9 India Patient Recruitment for Clinical Trials Consumption Value (2021-2032)

3 WORLD PATIENT RECRUITMENT FOR CLINICAL TRIALS COMPANIES COMPETITIVE ANALYSIS

3.1 World Patient Recruitment for Clinical Trials Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Patient Recruitment for Clinical Trials Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Patient Recruitment for Clinical Trials in 2025
  3.2.3 Global Concentration Ratios (CR8) for Patient Recruitment for Clinical Trials in 2025
3.3 Patient Recruitment for Clinical Trials Company Evaluation Quadrant
3.4 Patient Recruitment for Clinical Trials Market: Overall Company Footprint Analysis
  3.4.1 Patient Recruitment for Clinical Trials Market: Region Footprint
  3.4.2 Patient Recruitment for Clinical Trials Market: Company Product Type Footprint
  3.4.3 Patient Recruitment for Clinical Trials Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Patient Recruitment for Clinical Trials Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Patient Recruitment for Clinical Trials Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: Patient Recruitment for Clinical Trials Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Patient Recruitment for Clinical Trials Consumption Value Comparison
  4.2.1 United States VS China: Patient Recruitment for Clinical Trials Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Patient Recruitment for Clinical Trials Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Patient Recruitment for Clinical Trials Companies and Market Share, 2021-2026
  4.3.1 United States Based Patient Recruitment for Clinical Trials Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Patient Recruitment for Clinical Trials Revenue, (2021-2026)
4.4 China Based Companies Patient Recruitment for Clinical Trials Revenue and Market Share, 2021-2026
  4.4.1 China Based Patient Recruitment for Clinical Trials Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Patient Recruitment for Clinical Trials Revenue, (2021-2026)
4.5 Rest of World Based Patient Recruitment for Clinical Trials Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based Patient Recruitment for Clinical Trials Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies Patient Recruitment for Clinical Trials Revenue (2021-2026)

5 MARKET ANALYSIS BY CLINICAL TRIAL PHASE

5.1 World Patient Recruitment for Clinical Trials Market Size Overview by Clinical Trial Phase: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Clinical Trial Phase
  5.2.1 Phase I
  5.2.2 Phase II
  5.2.3 Phase III
  5.2.4 Phase IV
5.3 Market Segment by Clinical Trial Phase
  5.3.1 World Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (2021-2026)
  5.3.2 World Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (2027-2032)
  5.3.3 World Patient Recruitment for Clinical Trials Market Size Market Share by Clinical Trial Phase (2027-2032)

6 MARKET ANALYSIS BY CLIENT TYPE

6.1 World Patient Recruitment for Clinical Trials Market Size Overview by Client Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Client Type
  6.2.1 Pharmaceutical and Biotechnology Companies
  6.2.2 CROs and Research Organizations
  6.2.3 Others
6.3 Market Segment by Client Type
  6.3.1 World Patient Recruitment for Clinical Trials Market Size by Client Type (2021-2026)
  6.3.2 World Patient Recruitment for Clinical Trials Market Size by Client Type (2027-2032)
  6.3.3 World Patient Recruitment for Clinical Trials Market Size Market Share by Client Type (2027-2032)

7 MARKET ANALYSIS BY RECRUITMENT CHANNEL

7.1 World Patient Recruitment for Clinical Trials Market Size Overview by Recruitment Channel: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Recruitment Channel
  7.2.1 Online
  7.2.2 Offline
7.3 Market Segment by Recruitment Channel
  7.3.1 World Patient Recruitment for Clinical Trials Market Size by Recruitment Channel (2021-2026)
  7.3.2 World Patient Recruitment for Clinical Trials Market Size by Recruitment Channel (2027-2032)
  7.3.3 World Patient Recruitment for Clinical Trials Market Size Market Share by Recruitment Channel (2027-2032)

8 MARKET ANALYSIS BY THERAPEUTIC AREA

8.1 World Patient Recruitment for Clinical Trials Market Size Overview by Therapeutic Area: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Therapeutic Area
  8.2.1 Oncology
  8.2.2 Rare Disease
  8.2.3 CNS and Psychiatric
  8.2.4 Inflammatory Disorder
  8.2.5 Infectious Disease
  8.2.6 Others
8.3 Market Segment by Therapeutic Area
  8.3.1 World Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (2021-2026)
  8.3.2 World Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (2027-2032)
  8.3.3 World Patient Recruitment for Clinical Trials Market Size Market Share by Therapeutic Area (2021-2032)

9 COMPANY PROFILES

9.1 IQVIA
  9.1.1 IQVIA Details
  9.1.2 IQVIA Major Business
  9.1.3 IQVIA Patient Recruitment for Clinical Trials Product and Services
  9.1.4 IQVIA Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.1.5 IQVIA Recent Developments/Updates
  9.1.6 IQVIA Competitive Strengths & Weaknesses
9.2 Thermo Fisher Scientific (PPD)
  9.2.1 Thermo Fisher Scientific (PPD) Details
  9.2.2 Thermo Fisher Scientific (PPD) Major Business
  9.2.3 Thermo Fisher Scientific (PPD) Patient Recruitment for Clinical Trials Product and Services
  9.2.4 Thermo Fisher Scientific (PPD) Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.2.5 Thermo Fisher Scientific (PPD) Recent Developments/Updates
  9.2.6 Thermo Fisher Scientific (PPD) Competitive Strengths & Weaknesses
9.3 ICON plc
  9.3.1 ICON plc Details
  9.3.2 ICON plc Major Business
  9.3.3 ICON plc Patient Recruitment for Clinical Trials Product and Services
  9.3.4 ICON plc Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.3.5 ICON plc Recent Developments/Updates
  9.3.6 ICON plc Competitive Strengths & Weaknesses
9.4 Syneos Health
  9.4.1 Syneos Health Details
  9.4.2 Syneos Health Major Business
  9.4.3 Syneos Health Patient Recruitment for Clinical Trials Product and Services
  9.4.4 Syneos Health Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.4.5 Syneos Health Recent Developments/Updates
  9.4.6 Syneos Health Competitive Strengths & Weaknesses
9.5 Parexel
  9.5.1 Parexel Details
  9.5.2 Parexel Major Business
  9.5.3 Parexel Patient Recruitment for Clinical Trials Product and Services
  9.5.4 Parexel Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.5.5 Parexel Recent Developments/Updates
  9.5.6 Parexel Competitive Strengths & Weaknesses
9.6 Labcorp
  9.6.1 Labcorp Details
  9.6.2 Labcorp Major Business
  9.6.3 Labcorp Patient Recruitment for Clinical Trials Product and Services
  9.6.4 Labcorp Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.6.5 Labcorp Recent Developments/Updates
  9.6.6 Labcorp Competitive Strengths & Weaknesses
9.7 Medpace, Inc.
  9.7.1 Medpace, Inc. Details
  9.7.2 Medpace, Inc. Major Business
  9.7.3 Medpace, Inc. Patient Recruitment for Clinical Trials Product and Services
  9.7.4 Medpace, Inc. Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.7.5 Medpace, Inc. Recent Developments/Updates
  9.7.6 Medpace, Inc. Competitive Strengths & Weaknesses
9.8 WCG Clinical
  9.8.1 WCG Clinical Details
  9.8.2 WCG Clinical Major Business
  9.8.3 WCG Clinical Patient Recruitment for Clinical Trials Product and Services
  9.8.4 WCG Clinical Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.8.5 WCG Clinical Recent Developments/Updates
  9.8.6 WCG Clinical Competitive Strengths & Weaknesses
9.9 Science37
  9.9.1 Science37 Details
  9.9.2 Science37 Major Business
  9.9.3 Science37 Patient Recruitment for Clinical Trials Product and Services
  9.9.4 Science37 Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.9.5 Science37 Recent Developments/Updates
  9.9.6 Science37 Competitive Strengths & Weaknesses
9.10 Baidu Health
  9.10.1 Baidu Health Details
  9.10.2 Baidu Health Major Business
  9.10.3 Baidu Health Patient Recruitment for Clinical Trials Product and Services
  9.10.4 Baidu Health Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.10.5 Baidu Health Recent Developments/Updates
  9.10.6 Baidu Health Competitive Strengths & Weaknesses
9.11 Hangzhou Tigermed
  9.11.1 Hangzhou Tigermed Details
  9.11.2 Hangzhou Tigermed Major Business
  9.11.3 Hangzhou Tigermed Patient Recruitment for Clinical Trials Product and Services
  9.11.4 Hangzhou Tigermed Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.11.5 Hangzhou Tigermed Recent Developments/Updates
  9.11.6 Hangzhou Tigermed Competitive Strengths & Weaknesses
9.12 AutoCruitment
  9.12.1 AutoCruitment Details
  9.12.2 AutoCruitment Major Business
  9.12.3 AutoCruitment Patient Recruitment for Clinical Trials Product and Services
  9.12.4 AutoCruitment Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.12.5 AutoCruitment Recent Developments/Updates
  9.12.6 AutoCruitment Competitive Strengths & Weaknesses
9.13 Beijing Houpu Pharmaceutical
  9.13.1 Beijing Houpu Pharmaceutical Details
  9.13.2 Beijing Houpu Pharmaceutical Major Business
  9.13.3 Beijing Houpu Pharmaceutical Patient Recruitment for Clinical Trials Product and Services
  9.13.4 Beijing Houpu Pharmaceutical Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.13.5 Beijing Houpu Pharmaceutical Recent Developments/Updates
  9.13.6 Beijing Houpu Pharmaceutical Competitive Strengths & Weaknesses
9.14 Clariness
  9.14.1 Clariness Details
  9.14.2 Clariness Major Business
  9.14.3 Clariness Patient Recruitment for Clinical Trials Product and Services
  9.14.4 Clariness Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.14.5 Clariness Recent Developments/Updates
  9.14.6 Clariness Competitive Strengths & Weaknesses
9.15 Matthews Media Group (MMG)
  9.15.1 Matthews Media Group (MMG) Details
  9.15.2 Matthews Media Group (MMG) Major Business
  9.15.3 Matthews Media Group (MMG) Patient Recruitment for Clinical Trials Product and Services
  9.15.4 Matthews Media Group (MMG) Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.15.5 Matthews Media Group (MMG) Recent Developments/Updates
  9.15.6 Matthews Media Group (MMG) Competitive Strengths & Weaknesses
9.16 Trialbee
  9.16.1 Trialbee Details
  9.16.2 Trialbee Major Business
  9.16.3 Trialbee Patient Recruitment for Clinical Trials Product and Services
  9.16.4 Trialbee Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.16.5 Trialbee Recent Developments/Updates
  9.16.6 Trialbee Competitive Strengths & Weaknesses
9.17 Publicis
  9.17.1 Publicis Details
  9.17.2 Publicis Major Business
  9.17.3 Publicis Patient Recruitment for Clinical Trials Product and Services
  9.17.4 Publicis Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.17.5 Publicis Recent Developments/Updates
  9.17.6 Publicis Competitive Strengths & Weaknesses
9.18 Worldwide Clinical Trials
  9.18.1 Worldwide Clinical Trials Details
  9.18.2 Worldwide Clinical Trials Major Business
  9.18.3 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Product and Services
  9.18.4 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.18.5 Worldwide Clinical Trials Recent Developments/Updates
  9.18.6 Worldwide Clinical Trials Competitive Strengths & Weaknesses
9.19 Elixia
  9.19.1 Elixia Details
  9.19.2 Elixia Major Business
  9.19.3 Elixia Patient Recruitment for Clinical Trials Product and Services
  9.19.4 Elixia Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.19.5 Elixia Recent Developments/Updates
  9.19.6 Elixia Competitive Strengths & Weaknesses
9.20 Shanghai Jsure
  9.20.1 Shanghai Jsure Details
  9.20.2 Shanghai Jsure Major Business
  9.20.3 Shanghai Jsure Patient Recruitment for Clinical Trials Product and Services
  9.20.4 Shanghai Jsure Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.20.5 Shanghai Jsure Recent Developments/Updates
  9.20.6 Shanghai Jsure Competitive Strengths & Weaknesses
9.21 JD Health
  9.21.1 JD Health Details
  9.21.2 JD Health Major Business
  9.21.3 JD Health Patient Recruitment for Clinical Trials Product and Services
  9.21.4 JD Health Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.21.5 JD Health Recent Developments/Updates
  9.21.6 JD Health Competitive Strengths & Weaknesses
9.22 Waterdrop Inc.
  9.22.1 Waterdrop Inc. Details
  9.22.2 Waterdrop Inc. Major Business
  9.22.3 Waterdrop Inc. Patient Recruitment for Clinical Trials Product and Services
  9.22.4 Waterdrop Inc. Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.22.5 Waterdrop Inc. Recent Developments/Updates
  9.22.6 Waterdrop Inc. Competitive Strengths & Weaknesses
9.23 Antidote
  9.23.1 Antidote Details
  9.23.2 Antidote Major Business
  9.23.3 Antidote Patient Recruitment for Clinical Trials Product and Services
  9.23.4 Antidote Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
  9.23.5 Antidote Recent Developments/Updates
  9.23.6 Antidote Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 Patient Recruitment for Clinical Trials Industry Chain
10.2 Patient Recruitment for Clinical Trials Upstream Analysis
10.3 Patient Recruitment for Clinical Trials Midstream Analysis
10.4 Patient Recruitment for Clinical Trials Downstream Analysis

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer


LIST OF TABLES

Table 1. World Patient Recruitment for Clinical Trials Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Patient Recruitment for Clinical Trials Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Patient Recruitment for Clinical Trials Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Patient Recruitment for Clinical Trials Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Patient Recruitment for Clinical Trials Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Patient Recruitment for Clinical Trials Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Patient Recruitment for Clinical Trials Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Patient Recruitment for Clinical Trials Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Patient Recruitment for Clinical Trials Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Patient Recruitment for Clinical Trials Players in 2025
Table 12. World Patient Recruitment for Clinical Trials Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Patient Recruitment for Clinical Trials Company Evaluation Quadrant
Table 14. Head Office of Key Patient Recruitment for Clinical Trials Players
Table 15. Patient Recruitment for Clinical Trials Market: Company Product Type Footprint
Table 16. Patient Recruitment for Clinical Trials Market: Company Product Application Footprint
Table 17. Patient Recruitment for Clinical Trials Mergers & Acquisitions Activity
Table 18. United States VS China Patient Recruitment for Clinical Trials Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Patient Recruitment for Clinical Trials Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Patient Recruitment for Clinical Trials Companies, Headquarters (States, Country)
Table 21. United States Based Companies Patient Recruitment for Clinical Trials Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Patient Recruitment for Clinical Trials Revenue Market Share (2021-2026)
Table 23. China Based Patient Recruitment for Clinical Trials Companies, Headquarters (Province, Country)
Table 24. China Based Companies Patient Recruitment for Clinical Trials Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Patient Recruitment for Clinical Trials Revenue Market Share (2021-2026)
Table 26. Rest of World Based Patient Recruitment for Clinical Trials Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Patient Recruitment for Clinical Trials Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Patient Recruitment for Clinical Trials Revenue Market Share (2021-2026)
Table 29. World Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase, (USD Million), 2021 & 2025 & 2032
Table 30. World Patient Recruitment for Clinical Trials Market Size Value by Clinical Trial Phase (2021-2026) & (USD Million)
Table 31. World Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (2027-2032) & (USD Million)
Table 32. World Patient Recruitment for Clinical Trials Market Size by Client Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Patient Recruitment for Clinical Trials Market Size Value by Client Type (2021-2026) & (USD Million)
Table 34. World Patient Recruitment for Clinical Trials Market Size by Client Type (2027-2032) & (USD Million)
Table 35. World Patient Recruitment for Clinical Trials Market Size by Recruitment Channel, (USD Million), 2021 & 2025 & 2032
Table 36. World Patient Recruitment for Clinical Trials Market Size Value by Recruitment Channel (2021-2026) & (USD Million)
Table 37. World Patient Recruitment for Clinical Trials Market Size by Recruitment Channel (2027-2032) & (USD Million)
Table 38. World Patient Recruitment for Clinical Trials Market Size by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Table 39. World Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (2021-2026) & (USD Million)
Table 40. World Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (2027-2032) & (USD Million)
Table 41. IQVIA Basic Information, Manufacturing Base and Competitors
Table 42. IQVIA Major Business
Table 43. IQVIA Patient Recruitment for Clinical Trials Product and Services
Table 44. IQVIA Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. IQVIA Recent Developments/Updates
Table 46. IQVIA Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific (PPD) Basic Information, Manufacturing Base and Competitors
Table 48. Thermo Fisher Scientific (PPD) Major Business
Table 49. Thermo Fisher Scientific (PPD) Patient Recruitment for Clinical Trials Product and Services
Table 50. Thermo Fisher Scientific (PPD) Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Thermo Fisher Scientific (PPD) Recent Developments/Updates
Table 52. Thermo Fisher Scientific (PPD) Competitive Strengths & Weaknesses
Table 53. ICON plc Basic Information, Manufacturing Base and Competitors
Table 54. ICON plc Major Business
Table 55. ICON plc Patient Recruitment for Clinical Trials Product and Services
Table 56. ICON plc Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. ICON plc Recent Developments/Updates
Table 58. ICON plc Competitive Strengths & Weaknesses
Table 59. Syneos Health Basic Information, Manufacturing Base and Competitors
Table 60. Syneos Health Major Business
Table 61. Syneos Health Patient Recruitment for Clinical Trials Product and Services
Table 62. Syneos Health Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Syneos Health Recent Developments/Updates
Table 64. Syneos Health Competitive Strengths & Weaknesses
Table 65. Parexel Basic Information, Manufacturing Base and Competitors
Table 66. Parexel Major Business
Table 67. Parexel Patient Recruitment for Clinical Trials Product and Services
Table 68. Parexel Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Parexel Recent Developments/Updates
Table 70. Parexel Competitive Strengths & Weaknesses
Table 71. Labcorp Basic Information, Manufacturing Base and Competitors
Table 72. Labcorp Major Business
Table 73. Labcorp Patient Recruitment for Clinical Trials Product and Services
Table 74. Labcorp Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Labcorp Recent Developments/Updates
Table 76. Labcorp Competitive Strengths & Weaknesses
Table 77. Medpace, Inc. Basic Information, Manufacturing Base and Competitors
Table 78. Medpace, Inc. Major Business
Table 79. Medpace, Inc. Patient Recruitment for Clinical Trials Product and Services
Table 80. Medpace, Inc. Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Medpace, Inc. Recent Developments/Updates
Table 82. Medpace, Inc. Competitive Strengths & Weaknesses
Table 83. WCG Clinical Basic Information, Manufacturing Base and Competitors
Table 84. WCG Clinical Major Business
Table 85. WCG Clinical Patient Recruitment for Clinical Trials Product and Services
Table 86. WCG Clinical Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. WCG Clinical Recent Developments/Updates
Table 88. WCG Clinical Competitive Strengths & Weaknesses
Table 89. Science37 Basic Information, Manufacturing Base and Competitors
Table 90. Science37 Major Business
Table 91. Science37 Patient Recruitment for Clinical Trials Product and Services
Table 92. Science37 Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Science37 Recent Developments/Updates
Table 94. Science37 Competitive Strengths & Weaknesses
Table 95. Baidu Health Basic Information, Manufacturing Base and Competitors
Table 96. Baidu Health Major Business
Table 97. Baidu Health Patient Recruitment for Clinical Trials Product and Services
Table 98. Baidu Health Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Baidu Health Recent Developments/Updates
Table 100. Baidu Health Competitive Strengths & Weaknesses
Table 101. Hangzhou Tigermed Basic Information, Manufacturing Base and Competitors
Table 102. Hangzhou Tigermed Major Business
Table 103. Hangzhou Tigermed Patient Recruitment for Clinical Trials Product and Services
Table 104. Hangzhou Tigermed Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Hangzhou Tigermed Recent Developments/Updates
Table 106. Hangzhou Tigermed Competitive Strengths & Weaknesses
Table 107. AutoCruitment Basic Information, Manufacturing Base and Competitors
Table 108. AutoCruitment Major Business
Table 109. AutoCruitment Patient Recruitment for Clinical Trials Product and Services
Table 110. AutoCruitment Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. AutoCruitment Recent Developments/Updates
Table 112. AutoCruitment Competitive Strengths & Weaknesses
Table 113. Beijing Houpu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 114. Beijing Houpu Pharmaceutical Major Business
Table 115. Beijing Houpu Pharmaceutical Patient Recruitment for Clinical Trials Product and Services
Table 116. Beijing Houpu Pharmaceutical Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Beijing Houpu Pharmaceutical Recent Developments/Updates
Table 118. Beijing Houpu Pharmaceutical Competitive Strengths & Weaknesses
Table 119. Clariness Basic Information, Manufacturing Base and Competitors
Table 120. Clariness Major Business
Table 121. Clariness Patient Recruitment for Clinical Trials Product and Services
Table 122. Clariness Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Clariness Recent Developments/Updates
Table 124. Clariness Competitive Strengths & Weaknesses
Table 125. Matthews Media Group (MMG) Basic Information, Manufacturing Base and Competitors
Table 126. Matthews Media Group (MMG) Major Business
Table 127. Matthews Media Group (MMG) Patient Recruitment for Clinical Trials Product and Services
Table 128. Matthews Media Group (MMG) Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Matthews Media Group (MMG) Recent Developments/Updates
Table 130. Matthews Media Group (MMG) Competitive Strengths & Weaknesses
Table 131. Trialbee Basic Information, Manufacturing Base and Competitors
Table 132. Trialbee Major Business
Table 133. Trialbee Patient Recruitment for Clinical Trials Product and Services
Table 134. Trialbee Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Trialbee Recent Developments/Updates
Table 136. Trialbee Competitive Strengths & Weaknesses
Table 137. Publicis Basic Information, Manufacturing Base and Competitors
Table 138. Publicis Major Business
Table 139. Publicis Patient Recruitment for Clinical Trials Product and Services
Table 140. Publicis Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Publicis Recent Developments/Updates
Table 142. Publicis Competitive Strengths & Weaknesses
Table 143. Worldwide Clinical Trials Basic Information, Manufacturing Base and Competitors
Table 144. Worldwide Clinical Trials Major Business
Table 145. Worldwide Clinical Trials Patient Recruitment for Clinical Trials Product and Services
Table 146. Worldwide Clinical Trials Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Worldwide Clinical Trials Recent Developments/Updates
Table 148. Worldwide Clinical Trials Competitive Strengths & Weaknesses
Table 149. Elixia Basic Information, Manufacturing Base and Competitors
Table 150. Elixia Major Business
Table 151. Elixia Patient Recruitment for Clinical Trials Product and Services
Table 152. Elixia Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Elixia Recent Developments/Updates
Table 154. Elixia Competitive Strengths & Weaknesses
Table 155. Shanghai Jsure Basic Information, Manufacturing Base and Competitors
Table 156. Shanghai Jsure Major Business
Table 157. Shanghai Jsure Patient Recruitment for Clinical Trials Product and Services
Table 158. Shanghai Jsure Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Shanghai Jsure Recent Developments/Updates
Table 160. Shanghai Jsure Competitive Strengths & Weaknesses
Table 161. JD Health Basic Information, Manufacturing Base and Competitors
Table 162. JD Health Major Business
Table 163. JD Health Patient Recruitment for Clinical Trials Product and Services
Table 164. JD Health Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. JD Health Recent Developments/Updates
Table 166. JD Health Competitive Strengths & Weaknesses
Table 167. Waterdrop Inc. Basic Information, Manufacturing Base and Competitors
Table 168. Waterdrop Inc. Major Business
Table 169. Waterdrop Inc. Patient Recruitment for Clinical Trials Product and Services
Table 170. Waterdrop Inc. Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Waterdrop Inc. Recent Developments/Updates
Table 172. Waterdrop Inc. Competitive Strengths & Weaknesses
Table 173. Antidote Basic Information, Manufacturing Base and Competitors
Table 174. Antidote Major Business
Table 175. Antidote Patient Recruitment for Clinical Trials Product and Services
Table 176. Antidote Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Antidote Recent Developments/Updates
Table 178. Antidote Competitive Strengths & Weaknesses
Table 179. Global Key Players of Patient Recruitment for Clinical Trials Upstream (Raw Materials)
Table 180. Global Patient Recruitment for Clinical Trials Typical Customers

LIST OF FIGURES

Figure 1. Patient Recruitment for Clinical Trials Picture
Figure 2. World Patient Recruitment for Clinical Trials Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Patient Recruitment for Clinical Trials Total Revenue (2021-2032) & (USD Million)
Figure 4. World Patient Recruitment for Clinical Trials Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Patient Recruitment for Clinical Trials Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Patient Recruitment for Clinical Trials Revenue (2021-2032) & (USD Million)
Figure 13. Patient Recruitment for Clinical Trials Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Patient Recruitment for Clinical Trials Consumption Value (2021-2032) & (USD Million)
Figure 16. World Patient Recruitment for Clinical Trials Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Patient Recruitment for Clinical Trials Consumption Value (2021-2032) & (USD Million)
Figure 18. China Patient Recruitment for Clinical Trials Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Patient Recruitment for Clinical Trials Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Patient Recruitment for Clinical Trials Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Patient Recruitment for Clinical Trials Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Patient Recruitment for Clinical Trials Consumption Value (2021-2032) & (USD Million)
Figure 23. India Patient Recruitment for Clinical Trials Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Patient Recruitment for Clinical Trials by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Patient Recruitment for Clinical Trials Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Patient Recruitment for Clinical Trials Markets in 2025
Figure 27. United States VS China: Patient Recruitment for Clinical Trials Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Patient Recruitment for Clinical Trials Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase, (USD Million), 2021 & 2025 & 2032
Figure 30. World Patient Recruitment for Clinical Trials Market Size Market Share by Clinical Trial Phase in 2025
Figure 31. Phase I
Figure 32. Phase II
Figure 33. Phase III
Figure 34. Phase IV
Figure 35. World Patient Recruitment for Clinical Trials Market Size Market Share by Clinical Trial Phase (2021-2032)
Figure 36. World Patient Recruitment for Clinical Trials Market Size by Client Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World Patient Recruitment for Clinical Trials Market Size Market Share by Client Type in 2025
Figure 38. Pharmaceutical and Biotechnology Companies
Figure 39. CROs and Research Organizations
Figure 40. Others
Figure 41. World Patient Recruitment for Clinical Trials Market Size Market Share by Client Type (2021-2032)
Figure 42. World Patient Recruitment for Clinical Trials Market Size by Recruitment Channel, (USD Million), 2021 & 2025 & 2032
Figure 43. World Patient Recruitment for Clinical Trials Market Size Market Share by Recruitment Channel in 2025
Figure 44. Online
Figure 45. Offline
Figure 46. World Patient Recruitment for Clinical Trials Market Size Market Share by Recruitment Channel (2021-2032)
Figure 47. World Patient Recruitment for Clinical Trials Market Size by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Figure 48. World Patient Recruitment for Clinical Trials Market Size Market Share by Therapeutic Area in 2025
Figure 49. Oncology
Figure 50. Rare Disease
Figure 51. CNS and Psychiatric
Figure 52. Inflammatory Disorder
Figure 53. Infectious Disease
Figure 54. Others
Figure 55. World Patient Recruitment for Clinical Trials Market Size Market Share by Therapeutic Area (2021-2032)
Figure 56. Patient Recruitment for Clinical Trials Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source


More Publications